Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,090 | 7,402 | 8,031 | 14,134 | 26,734 |
| Receivables | 20,660 | 23,464 | 20,793 | 20,883 | 18,343 |
| Inventories | 23,011 | 23,068 | 22,092 | 20,531 | 18,063 |
| Income taxes - deferred | 2,563 | 2,608 | 1,855 | 1,515 | 1,546 |
| Other current assets | 0 | 0 | 0 | 0 | 315 |
| TOTAL | $52,324 | $56,542 | $52,771 | $57,063 | $65,001 |
| Non-Current Assets | |||||
| PPE Net | 5,934 | 5,764 | 5,581 | 5,190 | 4,109 |
| Intangibles | 23,044 | 23,766 | 24,133 | 62,227 | 53,894 |
| Other Non-Current Assets | 52,253 | 52,505 | 51,637 | 11,436 | 13,124 |
| TOTAL | $81,231 | $82,035 | $81,351 | $78,853 | $71,127 |
| Total Assets | $133,555 | $138,577 | $134,122 | $135,916 | $136,128 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 |
| Accounts payable and accrued liabilities | 6,322 | 8,834 | 7,180 | 6,294 | 5,052 |
| Accrued Expenses | 4,054 | 4,597 | 4,563 | 5,006 | 4,161 |
| Other current liabilities | 855 | 1,692 | 1,800 | 1,023 | 823 |
| TOTAL | $17,270 | $21,233 | $19,762 | $18,099 | $15,628 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,150 | 15,650 | 16,900 | 16,450 | 18,200 |
| Deferred Revenues | 795 | 864 | 980 | 655 | 592 |
| Other Non-Current Liabilities | 4,593 | 4,675 | 4,785 | 4,574 | 5,405 |
| TOTAL | $21,999 | $22,531 | $23,857 | $22,349 | $23,724 |
| Total Liabilities | $39,269 | $43,764 | $43,619 | $40,448 | $39,352 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,944 | 33,926 | 33,452 | 33,165 | 32,420 |
| Common Shares | 416 | 415 | 401 | 397 | 395 |
| Retained earnings | -94,583 | -93,736 | -94,085 | -92,684 | -92,670 |
| Other shareholders' equity | -11,202 | -10,659 | -12,431 | -7,901 | -5,337 |
| TOTAL | $94,286 | $94,813 | $90,503 | $95,468 | $96,776 |
| Total Liabilities And Equity | $133,555 | $138,577 | $134,122 | $135,916 | $136,128 |